drugset / Trial / NCT07049081
A Study of LUCAR-G79 in Subjects With Relapsed/Refractory Autoimmune Diseases
NaSingle-groupOpen-labelTreatment
Summary
This is a prospective, single-arm, open-label and dose-escalation Investigator Initialed study to evaluate LUCAR-G79 in adult subjects with relapsed/refractory autoimmune diseases.
Timeline
- Start
- 2025-07-17
- Primary completion
- 2026-03-20
- Completion
- 2026-03-20
Outcome
Outcome not reported
Stopped: “pipeline adjustment”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LUCAR-G79 T cells | Cell therapy | — | Other |
Indications
No indication recorded.